Melanotan II (MT-II) is a cyclic synthetic analogue of alpha-melanocyte stimulating hormone (α-MSH) with high affinity for melanocortin receptors MC1R through MC4R. Its diverse receptor profile has generated research interest across pigmentation, photoprotection, energy regulation, and reproductive biology.
Melanocortin Receptor System Background
The melanocortin system comprises five G-protein-coupled receptors (MC1R–MC5R) and their endogenous ligands — alpha, beta, and gamma-melanocyte stimulating hormones (MSH) and adrenocorticotropic hormone (ACTH), all derived from the proopiomelanocortin (POMC) precursor. These receptors mediate a remarkably diverse range of physiological functions, from skin pigmentation (MC1R) to energy homeostasis (MC3R/MC4R), immune modulation (MC1R/MC3R), and sexual function (MC4R).
Melanotan II (CAS: 121062-08-6; cyclic sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2) is a cyclic lactam analogue designed to increase metabolic stability over linear α-MSH. Its cyclization confers resistance to proteolytic degradation and lock the peptide in an active conformation, enhancing receptor binding affinity across MC1R, MC3R, MC4R, and MC5R.
MC1R and Pigmentation Research
MC1R activation in melanocytes triggers the cAMP/PKA signaling cascade, leading to CREB phosphorylation, MITF (microphthalmia-associated transcription factor) upregulation, and increased expression of enzymes in the melanin synthesis pathway (tyrosinase, TRP-1, TRP-2). This produces a shift from phaeomelanin (yellow/red pigment) to eumelanin (brown/black pigment) synthesis — a photoprotective response.
Research using B16F10 melanoma cells and primary human melanocyte cultures demonstrates that Melanotan II at nanomolar concentrations robustly stimulates dendrite formation, tyrosinase activity (DOPA oxidation assay), and melanin production (spectrophotometric measurement). Compared to linear α-MSH, MT-II produces more sustained melanocyte activation due to reduced proteolytic clearance.
Photoprotection Studies
A primary motivation for early Melanotan II research was the potential for photoprotection in individuals with fair skin and UV sensitivity. UV-induced DNA damage (cyclobutane pyrimidine dimers, CPD) is the initiating event in photocarcinogenesis. Research in UV-irradiated Mel-1 and Sk-Mel-28 cell lines demonstrates that pre-treatment with MT-II increases eumelanin content and reduces CPD formation per unit UV dose.
In pig skin models (considered the most translatable UV exposure model due to dermal and epidermal similarities to humans), repeated MT-II administration increased skin tanning (reflectance spectrophotometry) and reduced sunburn cell formation following standardized UV challenge. These photoprotection findings motivated interest in MT-II's potential as a research tool for UV damage biology.
MC4R and Energy Homeostasis Research
MC4R in the paraventricular nucleus (PVN) of the hypothalamus is a critical regulator of energy balance. MC4R activation reduces food intake and increases energy expenditure; MC4R deficiency in rodents and humans produces severe hyperphagic obesity. Melanotan II's high-affinity MC4R binding has made it a valuable pharmacological tool for dissecting the central melanocortin system's role in energy regulation.
In DIO mouse models and ob/ob mice, acute MT-II administration produces dose-dependent reductions in 24-hour food intake and increases in core body temperature (indicative of elevated energy expenditure). Chronic administration studies show sustained reductions in body weight and adipose tissue mass. These effects are blocked by SHU9119 (a MC3R/MC4R antagonist), confirming receptor specificity.
| Receptor | Tissue | Effect of MT-II Binding | Research Application |
|---|---|---|---|
| MC1R | Melanocytes, immune cells | Melanin synthesis, anti-inflammatory | Pigmentation, photoprotection research |
| MC3R | Hypothalamus, adipose | Energy balance modulation | Metabolic syndrome research |
| MC4R | Hypothalamus (PVN) | Reduced appetite, increased thermogenesis | Obesity and energy homeostasis research |
| MC4R | Spinal cord, brain | Pro-erectile signaling | Reproductive physiology research |
| MC5R | Exocrine glands | Secretion modulation | Exocrine function research |
Research Notes and Purity Requirements
For reliable receptor pharmacology research, MT-II should be used at defined concentrations with appropriate receptor selectivity controls. MC1R-selective compounds (e.g., BMS-470539) and MC4R-selective compounds can help dissect receptor-specific effects in mixed-receptor-expressing preparations. HPLC-verified purity (≥98%) is essential, as impurities can complicate receptor binding assays.
The nausea-like response observed in rodent studies at higher doses (reflecting area postrema MC4R activation) should be accounted for in experimental design through appropriate dose-ranging and behavioral monitoring.
Conclusion
Melanotan II's broad melanocortin receptor affinity profile makes it a versatile tool for research spanning pigmentation biology, photoprotection mechanisms, energy regulation, and neuroendocrine function. Its metabolic stability advantage over linear MSH analogues facilitates longer-duration cell culture and in vivo experiments. All research should be conducted under appropriate preclinical research protocols.
Research Use Only
All information in this article is provided for educational and informational purposes only. This content does not constitute medical advice. Products referenced are for in vitro scientific research only and are not intended for human consumption, clinical use, or self-administration. Always consult qualified research professionals.